ARTICLE | Clinical News
Neurodex regulatory update
February 6, 2006 8:00 AM UTC
AVN.R resubmitted an NDA for Neurodex to treat pseudobulbar affect (PBA). The new submission contains an expansion of summary analyses that better support the electronic common technical document form...